This inventor holds 8 USPTO granted patents and 3 published patent applications. Top assignees: University of Kansas, Hylapharm, LLC, Other. Active years: 2014-2025.
Location History:
- Lawrence, KS (US) (2019)
- Prairie Village, KS (US) (2014 - 2020)
- Mission Hills, KS (US) (2022)
Company Filing History:
6 out of 571 
2 out of 2 
1 out of 834,411 Years Active: 2014-2025
Title: The Innovative Contributions of Daniel J Aires
Introduction
Daniel J Aires is a notable inventor based in Prairie Village, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment and vaccine adjuvants. With a total of 8 patents to his name, Aires has established himself as a key figure in his area of expertise.
Latest Patents
Among his latest patents, Aires has developed imidazoquinoline compounds and prodrugs thereof. This technology focuses on TLR7 and TLR8 agonist compounds, compositions, and methods for treating cancers and enhancing vaccine efficacy. Another significant patent involves platinum(IV) conjugates and methods of use, which includes platinum(IV) compounds and their pharmaceutically acceptable salts, along with compositions and methods for their application.
Career Highlights
Throughout his career, Aires has worked with reputable organizations such as the University of Kansas and Hylapharm, LLC. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Aires has collaborated with esteemed colleagues, including Shuang Cai and Kenneth Ryan Moulder. These partnerships have further enriched his research and innovation efforts.
Conclusion
Daniel J Aires exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations have the potential to impact cancer treatment and vaccine development significantly.